Tashkent, Uzbekistan (UzDaily.uz) — Uzbekistan and Denmark discussed prospects for cooperation in pharmaceutical regulation during a video conference held on 11 August 2026, according to the Pharmaceutical Products Safety Center.
The meeting brought together representatives from Uzbekistan's Pharmaceutical Products Safety Center, the Danish Medicines Agency (DKMA), and the Embassy of Uzbekistan in Sweden.
During the conference, the Uzbek side presented details regarding the center's activities, authority, and main operational areas.
Discussions focused on the state registration and examination of medicines, pharmacovigilance, drug quality control, laboratory activities, pharmaceutical safety assurance, and the implementation of international standards.
The sides highlighted the importance of international standards and modern approaches in pharmaceutical regulation, professional capacity building, and knowledge sharing between regulatory bodies.
The Danish Medicines Agency serves as Denmark's state authority regulating medicines and medical devices. Its responsibilities include licensing and inspecting pharmaceutical companies, registering medicines, conducting clinical trials, managing pharmacovigilance, and monitoring medical device safety.
Special emphasis was placed on practical avenues for bilateral cooperation. The sides explored direct expert-level engagement, regulatory practice exchanges, training seminars, and professional development programs.
Possibilities for joint initiatives aimed at enhancing the professional skills of pharmaceutical industry specialists were also discussed.
